Adial Pharmaceuticals Cash from Financing (Quarterly) Analysis

Adial Pharmaceuticals Inc (ADIL)

1.52 +0.11 (+7.80%) USD | NASDAQ | May 17, 16:00

1.52 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	3.384M
September 30, 2023	0.1387M
June 30, 2023	0.0001M
March 31, 2023	0.6096M
December 31, 2022	0.00
September 30, 2022	0.00
June 30, 2022	0.0019M
March 31, 2022	9.124M
December 31, 2021	1.255M
September 30, 2021	5.50M
June 30, 2021	2.809M
March 31, 2021	4.080M
December 31, 2020	0.00
September 30, 2020	0.95M

Date	Value
June 30, 2020	4.657M
March 31, 2020	0.00
December 31, 2019	0.0001M
September 30, 2019	0.0002M
June 30, 2019	0.00
March 31, 2019	9.246M
December 31, 2018	0.1563M
September 30, 2018	5.658M
June 30, 2018	0.285M
March 31, 2018	0.25M
December 31, 2017	0.10M
September 30, 2017	0.04M
June 30, 2017	0.25M
March 31, 2017	0.00

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

Minimum

Mar 2020

9.124M

Maximum

Mar 2022

1.711M

Average

0.1387M

Median

Sep 2023

Cash from Financing (Quarterly) Benchmarks

BioVie Inc	4.922M
BioSig Technologies Inc	2.747M
Precision BioSciences Inc	40.10M
Humacyte Inc	62.80M
Monogram Orthopaedics Inc	0.1507M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-1.223M
Cash from Investing (Quarterly)	0.35M
Free Cash Flow	-6.807M
Free Cash Flow Per Share (Quarterly)	-0.735
Free Cash Flow Yield	-349.1%